a ropinirol - matokeo ya utafutaji kwa

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

ropinirole arw ropinirole (as hydrochloride) 2mg tablet blister pack

arrotex pharmaceuticals pty ltd - ropinirole hydrochloride, quantity: 2.28 mg (equivalent: ropinirole, qty 2 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; laureth-8 - repreve is indicated for the treatment of primary restless legs syndrome, including the reduction of associated periodic limb movement and episodes of nocturnal arousal.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

ropinirole arw ropinirole (as hydrochloride) 0.5 mg tablet blister pack

arrotex pharmaceuticals pty ltd - ropinirole hydrochloride, quantity: 0.57 mg (equivalent: ropinirole, qty 0.5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; iron oxide yellow; iron oxide red; laureth-8 - repreve is indicated for the treatment of primary restless legs syndrome, including the reduction of associated periodic limb movement and episodes of nocturnal arousal.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

ropinirole arw ropinirole (as hydrochloride) 0.25mg tablet blister pack

arrotex pharmaceuticals pty ltd - ropinirole hydrochloride, quantity: 0.285 mg (equivalent: ropinirole, qty 0.25 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; croscarmellose sodium; magnesium stearate; titanium dioxide; hypromellose; polysorbate 80; macrogol 400 - repreve is indicated for the treatment of primary restless legs syndrome, including the reduction of associated periodic limb movement and episodes of nocturnal arousal.